Corrigendum to "First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis": Annals of Oncology 2021; volume 32: 983-993
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2 August 2021
|
| In: |
Annals of oncology
Year: 2021, Jahrgang: 32, Heft: 10, Pages: 1308 |
| ISSN: | 1569-8041 |
| DOI: | 10.1016/j.annonc.2021.07.013 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.annonc.2021.07.013 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753421022110 
|
| Verfasserangaben: | L.A. Emens, S. Adams, C.H. Barrios, V. Diéras, H. Iwata, S. Loi, H.S. Rugo, A. Schneeweiss, E.P. Winer, S. Patel, V. Henschel, A. Swat, M. Kaul, L. Molinero, S. Patel, S.Y. Chui & P. Schmid |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1788429648 | ||
| 003 | DE-627 | ||
| 005 | 20251101215632.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220203s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.annonc.2021.07.013 |2 doi | |
| 035 | |a (DE-627)1788429648 | ||
| 035 | |a (DE-599)KXP1788429648 | ||
| 035 | |a (OCoLC)1341441286 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Emens, Leisha Ann |e VerfasserIn |0 (DE-588)1139674196 |0 (DE-627)897410122 |0 (DE-576)493389598 |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis" |b Annals of Oncology 2021; volume 32: 983-993 |c L.A. Emens, S. Adams, C.H. Barrios, V. Diéras, H. Iwata, S. Loi, H.S. Rugo, A. Schneeweiss, E.P. Winer, S. Patel, V. Henschel, A. Swat, M. Kaul, L. Molinero, S. Patel, S.Y. Chui & P. Schmid |
| 264 | 1 | |c 2 August 2021 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.02.2022 | ||
| 700 | 1 | |a Adams, S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Barrios, C. H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Diéras, V. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Iwata, H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Loi, S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rugo, H. S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 700 | 1 | |a Winer, E. P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Patel, S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Henschel, V. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Swat, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kaul, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Molinero, L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chui, S. Y. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmid, P. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 32(2021), 10 vom: Okt., Seite 1308 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Corrigendum to "First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis" Annals of Oncology 2021; volume 32: 983-993 |
| 773 | 1 | 8 | |g volume:32 |g year:2021 |g number:10 |g month:10 |g pages:1308 |g extent:1 |a Corrigendum to "First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis" Annals of Oncology 2021; volume 32: 983-993 |
| 787 | 0 | 8 | |i Errata zu |a Emens, Leisha Ann |t First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis |d 2021 |w (DE-627)1775911276 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.annonc.2021.07.013 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0923753421022110 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220203 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |d 50000 |e 910000PS109972554 |e 910400PS109972554 |e 50000PS109972554 |k 0/910000/ |k 1/910000/910400/ |k 0/50000/ |p 8 | ||
| 999 | |a KXP-PPN1788429648 |e 405070711X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 03.02.2022"],"recId":"1788429648","person":[{"given":"Leisha Ann","display":"Emens, Leisha Ann","family":"Emens","role":"aut"},{"display":"Adams, S.","given":"S.","family":"Adams","role":"aut"},{"given":"C. H.","display":"Barrios, C. H.","family":"Barrios","role":"aut"},{"family":"Diéras","role":"aut","display":"Diéras, V.","given":"V."},{"family":"Iwata","role":"aut","display":"Iwata, H.","given":"H."},{"display":"Loi, S.","given":"S.","role":"aut","family":"Loi"},{"display":"Rugo, H. S.","given":"H. S.","family":"Rugo","role":"aut"},{"given":"Andreas","display":"Schneeweiss, Andreas","role":"aut","family":"Schneeweiss"},{"family":"Winer","role":"aut","display":"Winer, E. P.","given":"E. P."},{"family":"Patel","role":"aut","given":"S.","display":"Patel, S."},{"display":"Henschel, V.","given":"V.","role":"aut","family":"Henschel"},{"given":"A.","display":"Swat, A.","role":"aut","family":"Swat"},{"role":"aut","family":"Kaul","display":"Kaul, M.","given":"M."},{"given":"L.","display":"Molinero, L.","family":"Molinero","role":"aut"},{"given":"S. Y.","display":"Chui, S. Y.","family":"Chui","role":"aut"},{"display":"Schmid, P.","given":"P.","family":"Schmid","role":"aut"}],"name":{"displayForm":["L.A. Emens, S. Adams, C.H. Barrios, V. Diéras, H. Iwata, S. Loi, H.S. Rugo, A. Schneeweiss, E.P. Winer, S. Patel, V. Henschel, A. Swat, M. Kaul, L. Molinero, S. Patel, S.Y. Chui & P. Schmid"]},"language":["eng"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"2 August 2021"}],"relHost":[{"disp":"Corrigendum to \"First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis\" Annals of Oncology 2021; volume 32: 983-993Annals of oncology","type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"display":"European Society for Medical Oncology","role":"isb"}],"pubHistory":["1.1990 -"],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"part":{"year":"2021","volume":"32","text":"32(2021), 10 vom: Okt., Seite 1308","pages":"1308","extent":"1","issue":"10"},"language":["eng"],"origin":[{"dateIssuedKey":"1990","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedDisp":"1990-"}],"id":{"issn":["1569-8041"],"eki":["320428796"],"zdb":["2003498-2"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology","title_sort":"Annals of oncology"}],"recId":"320428796"}],"id":{"eki":["1788429648"],"doi":["10.1016/j.annonc.2021.07.013"]},"physDesc":[{"extent":"1 S."}],"title":[{"title":"Corrigendum to \"First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis\"","subtitle":"Annals of Oncology 2021; volume 32: 983-993","title_sort":"Corrigendum to \"First-line atezolizumab plus nab-paclitaxel for unresectable locally advanced or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis\""}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a EMENSLEISHCORRIGENDU2202 | ||